New setbacks for Euroapi, resulting from a split with Sanofi. The specialist in active ingredients has suspended production at one of its sites until further notice.
A site about to be sold In the meantime, the 2024 financial outlook is also suspended… This article is reserved for subscribers. You have 69% left to discover. Flash sale €4.49/month for 12 months I ENJOY IT Already subscribed? Log in to the page you came from.